COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,632 Articles (21,885 medRxiv, 7,747 bioRxiv)

Most recent first Previous |  Page 2952: Articles 29511-29520  | Next

Estimating the daily trend in the size of COVID-19 infected population in Wuhan
Lin, Q., Hu, T., Zhou, X.-H.
10.1101/2020.02.12.20022277 — Posted: 2020-02-13
Serial interval of novel coronavirus (2019-nCoV) infections
Nishiura, H., Linton, N. M., Akhmetzhanov, A. R.
10.1101/2020.02.03.20019497 — Posted: 2020-02-13
ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection
Fan, C., Li, K., Ding, Y., Lu, W. L., Wang, J.
10.1101/2020.02.12.20022418 — Posted: 2020-02-13 Discussion: Onsite
Statistics based predictions of coronavirus 2019-nCoV spreading in mainland China
Nesteruk, I.
10.1101/2020.02.12.20021931 — Posted: 2020-02-13 Discussion: Onsite
Interventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2
Clifford, S. J., Klepac, P., Van Zandvoort, K., Quilty, B. J., CMMID nCoV working group, , Eggo, R. M., Flasche, S.
10.1101/2020.02.12.20022426 — Posted: 2020-02-13
Teicoplanin potently blocks the cell entry of 2019-nCoV
Zhang, J., Ma, X., Yu, F., Liu, J., Zou, F., Pan, T., Zhang, H.
10.1101/2020.02.05.935387 — Posted: 2020-02-13
Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019
Wong, M. C., Javornik Cregeen, S. J., Ajami, N. J., Petrosino, J. F.
10.1101/2020.02.07.939207 — Posted: 2020-02-13 Discussion: Onsite
Potentially highly potent drugs for 2019-nCoV
Nguyen, D., Gao, K., Chen, J., Wang, R., Wei, G.
10.1101/2020.02.05.936013 — Posted: 2020-02-13
Caution on Kidney Dysfunctions of 2019-nCoV Patients
Anti-2019-nCoV Volunteers, , Li, Z., Wu, M., Guo, J., Yao, J., Liao, X., Song, S., Han, M., Li, J., Duan, G., Zhou, Y., Wu, X., Zhou, Z., Wang, T., Hu, M., Chen, X., Fu, Y., Lei, C., Dong, H., Zhou, Y., Jia, H., Chen, X., Yan, J.
10.1101/2020.02.08.20021212 — Posted: 2020-02-12 Discussion: Onsite
Statistical Inference for Coronavirus Infected Patients in Wuhan
Zhou, Y., Dong, J.
10.1101/2020.02.10.20021774 — Posted: 2020-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).